Presión arterial : ¿esfigmomanómetro manual o digital?

El presente es un estudio prospectivo y comparativo entre la medición de la presión arterial obtenida de manera manual con esfigmomanómetro aneroide y la obtenida mediante monitor automático. El desarrollo de la práctica se realizó sobre un grupo de 100 pacientes hospitalizados en el servicio de Neurocirugía y Otorrinolaringología del Consorcio Hospital General de Valencia durante el primer trimestre del año 2007, mediante mediciones secuenciales y efectuadas por el mismo observador con ambos aparatos bien calibrados. Se observó mediante el método de correlación bivariada de Pearson que no existen diferencias estadísticamente significativas entre las presiones tomadas por ambos aparatos determinando así la fiabilidad del aparato automático utilizado en esta sala para el registro de la tensión arterial.This is a prospective and comparative work between arterial pressure obtained through manual measurement with aneroid sphygmomanometer and the arterial pressure obtained through automatic monitor. The practice was carried out in a group of 100 inpatients in the Neurosurgery and Otolaryngology Service in the Consortium of the General Hospital of Valencia during the first term of 2007. The development of this hospital training was made on each individual through sequential measurements and executed by the same observer with both well-calibrated machines. It was observed that through the method of Pearson's bivaried correlation there are not statistically significant differences between the pressures taken by both machines. As regards this fact, both automatic machines of arterial pressure register are [email protected] [email protected]

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Arterial pressure: manual or digital sphygmomanometer?

El presente es un estudio prospectivo y comparativo entre la medición de la presión arterial obtenida de manera manual con esfigmomanómetro aneroide y la obtenida mediante monitor automático. El desarrollo de la práctica se realizó sobre un grupo de 100 pacientes hospitalizados en el servicio de Neurocirugía y Otorrinolaringología del Consorcio Hospital General de Valencia durante el primer trimestre del año 2007, mediante mediciones secuenciales y efectuadas por el mismo observador con ambos aparatos bien calibrados. Se observó mediante el método de correlación bivariada de Pearson que no existen diferencias estadísticamente significativas entre las presiones tomadas por ambos aparatos determinando así la fiabilidad del aparato automático utilizado en esta sala para el registro de la tensión arterial.SUMMARY This is a prospective and comparative work between arterial pressure obtained through manual measurement with aneroid sphygmomanometer and the arterial pressure obtained through automatic monitor. The practice was carried out in a group of 100 inpatients in the Neurosurgery and Otolaryngology Service in the Consortium of the General Hospital of Valencia during the first term of 2007. The development of this hospital training was made on each individual through sequential measurements and executed by the same observer with both well-calibrated machines